CLINICAL_TRIALS ClinicalTrials.gov record update

Immunogenicity and Safety of the Sanofi Pasteur's DTacP-IPV//PRP~T Combined Vaccine (PENTAXIM™) Versus Sanofi Pasteur's DTacP-IPV Combined Vaccine (TETRAXIM™) Given Simultaneously at Separate Sites With PRP~T Conjugate Vaccine (ACTHIB™) as a Three-dose Primary Vaccination at 2, 4 and 6 Months of Age in South Korean Infants

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01214889
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:35:20.727758+00:00
Published At: 2012-04-17T00:00:00+00:00
Record Updated At: 2012-04-17
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Diphtheria", "Tetanus", "Pertussis", "Poliomyelitis", "Haemophilus Influenzae Type B"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2012-04-17"
protocolSection.identificationModule.nctId: "NCT01214889"
protocolSection.identificationModule.officialTitle: "Immunogenicity and Safety of the Sanofi Pasteur\u0027s DTacP-IPV//PRP~T Combined Vaccine (PENTAXIM\u2122) Versus Sanofi Pasteur\u0027s DTacP-IPV Combined Vaccine (TETRAXIM\u2122) Given Simultaneously at Separate Sites With PRP~T Conjugate Vaccine (ACTHIB\u2122) as a Three-dose Primary Vaccination at 2, 4 and 6 Months of Age in South Korean Infants"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.